WO2001011047A3 - Dna sequences isolated from human colonic epithelial cells - Google Patents

Dna sequences isolated from human colonic epithelial cells Download PDF

Info

Publication number
WO2001011047A3
WO2001011047A3 PCT/US2000/021606 US0021606W WO0111047A3 WO 2001011047 A3 WO2001011047 A3 WO 2001011047A3 US 0021606 W US0021606 W US 0021606W WO 0111047 A3 WO0111047 A3 WO 0111047A3
Authority
WO
WIPO (PCT)
Prior art keywords
epithelial cells
dna sequences
sequences isolated
human colonic
colonic epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/021606
Other languages
French (fr)
Other versions
WO2001011047A2 (en
Inventor
Bruce M Boman
Liangjun Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CA*TX Inc
Original Assignee
CA*TX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CA*TX Inc filed Critical CA*TX Inc
Priority to EP00952627A priority Critical patent/EP1206540A2/en
Priority to AU65290/00A priority patent/AU6529000A/en
Priority to JP2001515833A priority patent/JP2003510026A/en
Publication of WO2001011047A2 publication Critical patent/WO2001011047A2/en
Publication of WO2001011047A3 publication Critical patent/WO2001011047A3/en
Anticipated expiration legal-status Critical
Priority to US10/089,887 priority patent/US20030219740A1/en
Priority to US11/603,483 priority patent/US20070231814A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention discloses novel nucleic acid sequences which are implicated in the growth regulation of the epithelial cells of the colon, and which sequences are differentially expressed in cancerous colon tissues compared to normal colon tissues. These sequences are useful in diagnosing abnormal cell growth, treatment of abnormal cell growth and screening assays for treatments of abnormal cell growth.
PCT/US2000/021606 1999-08-09 2000-08-08 Dna sequences isolated from human colonic epithelial cells Ceased WO2001011047A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP00952627A EP1206540A2 (en) 1999-08-09 2000-08-08 Dna sequences isolated from human colonic epithelial cells
AU65290/00A AU6529000A (en) 1999-08-09 2000-08-08 Dna sequences isolated from human colonic epithelial cells
JP2001515833A JP2003510026A (en) 1999-08-09 2000-08-08 DNA sequence isolated from human colon epithelial cells
US10/089,887 US20030219740A1 (en) 1999-08-09 2002-03-29 DNA sequences isolated from human colonic epithelial cells
US11/603,483 US20070231814A1 (en) 1999-08-09 2006-11-21 DNA sequences isolated from human colonic epithelial cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14793399P 1999-08-09 1999-08-09
US60/147,933 1999-08-09

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/089,887 Continuation US20030219740A1 (en) 1999-08-09 2002-03-29 DNA sequences isolated from human colonic epithelial cells

Publications (2)

Publication Number Publication Date
WO2001011047A2 WO2001011047A2 (en) 2001-02-15
WO2001011047A3 true WO2001011047A3 (en) 2001-10-04

Family

ID=22523514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/021606 Ceased WO2001011047A2 (en) 1999-08-09 2000-08-08 Dna sequences isolated from human colonic epithelial cells

Country Status (5)

Country Link
US (2) US20030219740A1 (en)
EP (1) EP1206540A2 (en)
JP (1) JP2003510026A (en)
AU (1) AU6529000A (en)
WO (1) WO2001011047A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258973B2 (en) 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
CN101872135B (en) * 2002-12-10 2013-07-31 株式会社尼康 Exposure system and device producing method
US8348856B1 (en) 2008-12-16 2013-01-08 Zanetta Malanowska-Stega Simultaneous multiple method out-patient uterus biopsy device and method
MX2019006793A (en) 2016-12-09 2019-11-18 Zanetta Malanowska Stega DEVICE, KIT AND BRUSH METHODS FOR BIOPSY.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 10 August 2000 (2000-08-10), KAIRO A ET AL: "Isolation of novel genes from human colonic epithelial cells; Homo sapiens CATX-1 mRNA", XP002159513 *
HO SAMUEL B ET AL: "Heterogeneity of mucin gene expression in normal and neoplastic tissues.", CANCER RESEARCH, vol. 53, no. 3, 1993, pages 641 - 651, XP002159512, ISSN: 0008-5472 *
See also references of EP1206540A2 *

Also Published As

Publication number Publication date
WO2001011047A2 (en) 2001-02-15
AU6529000A (en) 2001-03-05
EP1206540A2 (en) 2002-05-22
US20030219740A1 (en) 2003-11-27
US20070231814A1 (en) 2007-10-04
JP2003510026A (en) 2003-03-18

Similar Documents

Publication Publication Date Title
WO1999064576A3 (en) Human genes differentially expressed in colon cancer
WO2006092668A3 (en) Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
WO2004076639A3 (en) Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
WO2002046465A3 (en) Method for identification of genes involved in specific diseases
WO2005044990A3 (en) Use of differentially expressed nucleic acid sequences as biomarkers for cancer
EP0961833A4 (en) HUMAN PLASMA HYALURONIDASE
WO2004063362A3 (en) Cell cycle progression proteins
WO2001083729A3 (en) Vectors for ocular transduction and use thereof for genetic therapy
WO2001052904A3 (en) Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides
WO1999046385A3 (en) Compositions and methods for the treatment and prevention of metastatic disorders
WO2002048329A3 (en) Membrane derived caspase-3, compositions comprising the same and methods of use therefor
WO2002078526A3 (en) Cancer-testis antigens
Koshiji et al. Microsatellite analysis of fecal DNA for colorectal cancer detection
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2002012440A3 (en) Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
AU2002219137A1 (en) Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
WO2004035741A3 (en) Susceptibility gene for myocardial infarction; methods of treatment
WO2003062826A3 (en) Materials and methods for examining and treating nasopharyngeal carcinoma
WO2000058510A3 (en) Schizophrenia associated genes, proteins and biallelic markers
WO2004050860A3 (en) Compositions, splice variants and methods relating to colon specific genes and proteins
WO2001007644A3 (en) Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
WO2003054167A3 (en) Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
WO2003027633A3 (en) Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
WO2001072773A3 (en) Genes isolated from dendritic cells, gene products and methods employing the same
WO2000058464A3 (en) Rab genes and their uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000952627

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10089887

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000952627

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642